TY - JOUR
T1 - Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosis
AU - Hoffmann, Friederike
AU - Fröhlich, Anne
AU - Schäfer, Niklas
AU - Keil, Vera C.
AU - Landsberg, Jennifer
AU - Herrlinger, Ulrich
AU - Sirokay, Judith
PY - 2020/5/1
Y1 - 2020/5/1
KW - Adult
KW - Antibodies, Monoclonal, Humanized/therapeutic use
KW - Antigens, CD20/immunology
KW - Antineoplastic Agents, Immunological/therapeutic use
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Brain Neoplasms/drug therapy
KW - Chemotherapy, Adjuvant/methods
KW - Glucocorticoids/therapeutic use
KW - Humans
KW - Imidazoles/therapeutic use
KW - Interferon-beta/therapeutic use
KW - Male
KW - Melanoma/complications
KW - Multiple Sclerosis/complications
KW - Neoplasm Recurrence, Local/complications
KW - Oximes/therapeutic use
KW - Polyethylene Glycols/therapeutic use
KW - Pyridones/therapeutic use
KW - Pyrimidinones/therapeutic use
KW - Skin Neoplasms/complications
KW - Treatment Outcome
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084113937&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/32096240
U2 - https://doi.org/10.1111/1346-8138.15272
DO - https://doi.org/10.1111/1346-8138.15272
M3 - Comment/Letter to the editor
C2 - 32096240
SN - 0385-2407
VL - 47
SP - e184-e185
JO - The Journal of dermatology
JF - The Journal of dermatology
IS - 5
ER -